| Dyno Debuts With Plan, Partnerships for Better Gene Therapy Vectors | Sarah de Crescenzo | 05/11/20 | Boston |
| To Infinity and Beyond: Julian Adams on Missteps and His New Job | Ben Fidler | 04/03/17 | Boston |
| Biotech Vet Dunsire’s New Challenge: Grow Tiny Startup, XTuit | Ben Fidler | 03/08/17 | Boston |
| Harvard Unveils $15M Life Lab to House Biotech and Medical Startups | Gregory T. Huang | 06/08/16 | Boston |
| Biogen, Arsia Team Up to Improve Hemophilia Drugs in $100M Pact | Ben Fidler | 12/16/15 | Boston |
| American Copycats: Can Biosimilars Catch On And Cut Costs In U.S.? | Alex Lash | 09/15/15 | National |
| East Coast Biotech Roundup: XTuit, Spero, Unum, RNAi Feud & More | Ben Fidler | 06/12/15 | Boston |
| XTuit Gets $22M From NEA, Polaris to Battle Cancer, Liver Disease | Ben Fidler | 06/11/15 | Boston |
| John Maraganore: From “Prototypical Geek” To Canny Alnylam Chief | Ben Fidler | 09/07/14 | Boston |
| Polaris’s Dogpatch Labs Evolving in Boston, Dublin, Closing in NY, Palo Alto | Gregory T. Huang | 01/11/13 | Boston |
| Cerulean Pharma Makes Progress in Attacking the Big C with Tiny Drugs | Ryan McBride | 09/07/10 | Boston |
| Boston’s Autism Mini-Cluster: New Drugs and Diagnostics Target Mysterious Brain Disorders | Ryan McBride | 07/22/10 | Boston |
| Notes from Dogpatch Labs’ Housewarming Party—and a List of Initial Inhabitants | Robert Buderi | 10/20/09 | Boston |
| Polaris to Open Dog Patch Labs Incubator in Cambridge | Robert Buderi | 09/10/09 | Boston |
| I-Therapeutix Raises $15M in Round Led by Polaris | Ryan McBride | 06/19/09 | Boston |
| Brightcove Forges Adobe Alliance, Investors Give in to DemandWare’s $15M Demands, Fate Therapeutics and Stemgent Team Up on Stem Cell Tech, & More Boston-Area Deals News | Rebecca Zacks | 04/24/09 | Boston |
| Parasol Therapeutics Moves to Neighborhood with $3.25M in Seed Funding—Hunting for Universal Therapeutic to Battle Drug-Resistant Flu | Ryan McBride | 04/22/09 | Boston |
| Biogen and Icahn Duel Again, Marinus Gets $20M, Vigilance Urged on Patent Reform, & More Boston-Area Life Sciences News | Rebecca Zacks | 04/15/09 | Boston |
| Fetzer New CEO of Cerulean Pharma | Ryan McBride | 04/08/09 | Boston |
